Your browser doesn't support javascript.
loading
Filler-induced blindness "seen" by ophthalmologists: Case presentation and treatment algorithm.
Martel, A; Lagier, J; Sarfati, E; Malet, T; Rocher, F; Kauert, A; Baillif, S; Chignon-Sicard, B.
Afiliación
  • Martel A; Ophthalmology department, University Hospital of Nice, Cote d'Azur University, 30, voie romaine, 06000 Nice, France. Electronic address: arnaudmartel@hotmail.fr.
  • Lagier J; Ophthalmology department, University Hospital of Nice, Cote d'Azur University, 30, voie romaine, 06000 Nice, France.
  • Sarfati E; Ophthalmology department, Toulon Hospital, Toulon, France.
  • Malet T; Monticelli eye centre, Marseille, France.
  • Rocher F; Pharmacovigilance department, University Hospital of Nice, 30, voie romaine, 06000 Nice, France.
  • Kauert A; Hyperbaric oxygen department, University Hospital of Nice, 30, voie romaine, 06000 Nice, France.
  • Baillif S; Ophthalmology department, University Hospital of Nice, Cote d'Azur University, 30, voie romaine, 06000 Nice, France.
  • Chignon-Sicard B; Plastic and reconstructive department, University Hospital of Nice, Cote d'Azur University, 30, voie romaine, 06000 Nice, France.
J Fr Ophtalmol ; 45(7): 771-783, 2022 Sep.
Article en En | MEDLINE | ID: mdl-35718568
PURPOSE: Filler-induced blindness (FIB) is the most threatening complication following periocular injection. To date, no standard of care has been established. The goal of this study is to report a new case of FIB with partial visual recovery and present our personalized algorithm for treatment based on fluorescein angiography findings. MATERIALS AND METHODS: Case report with 24 months follow-up and treatment algorithm. RESULTS: Our patient experienced complete vision loss to no light perception following forehead lipofilling. Retinal angiography identified a posterior ciliary artery occlusion. Antiplatelet medication, steroids and intraocular pressure lowering medications were administrated, followed by hyperbaric oxygen treatment (HBOT). Visual acuity improved to +0.8 logMar. The HBOT treatment was monitored by fluorescein angiogram. Based on this case and on the ophthalmic literature on retinal and ciliary artery occlusion, we established a personalized FIB protocol guided by fluorescein angiography. CONCLUSION: Although prevention remains the best treatment, all physicians should be prepared to manage FIB. Prompt management at the office guided by written protocols, as well as emergency kits, are essential. In referral centers, personalized treatment should be undertaken based on fluorescein angiography findings.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Oclusión de la Arteria Retiniana / Oftalmólogos Tipo de estudio: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: J Fr Ophtalmol Año: 2022 Tipo del documento: Article Pais de publicación: Francia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Oclusión de la Arteria Retiniana / Oftalmólogos Tipo de estudio: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: J Fr Ophtalmol Año: 2022 Tipo del documento: Article Pais de publicación: Francia